Explore alternative funding opportunities and how to enter a fast-growing healthcare market in 2019. We bring 100+ Chinese companies and investors seeking partnerships in biotech and pharma products. Meet more decision makers than you can in any event along the year!
China Focus@JPM Week
Jan 6th, 2019
JW Marriott San Francisco Union Square,
515 Mason St, San Francisco, CA 94102
We are delighted to announce a new lunch talk added to the program:
Lunch Talk Topic:
Navigating Beyond Borders:
Key Strategic Considerations for China BioPharma in a Global Market
James Lee, PhD
Associate Principal, Oncology Lead
Cello Health BioConsulting,
Previously Defined Health
“China has truly emerged as a major player in the pharmaceutical industry. Propelled by recent changes to regulatory and funding environments supporting China’s aspirations to be a global leader in innovative therapeutics, China is becoming a destination for licensing and partnering deals. Buoyed by the recent change in HKEX in allowing pre-revenue listings, there has been a significant increase in listings in HK with the high valuations. China’s intention to develop innovative therapeutics has led to an explosion of licensing and partnering deals. The increase in Chinese capital investments and deals will lead to an exciting future, but using the recent downswing of HKEX biotech stocks as one metric, one could well argue that there is a need for more analysis as part of the due diligence around those programs worth moving forward, including deeper assessment of scientific merit, clinical utility, global regulatory, clinical, commercial and payer access considerations.”
Our partnering system is open now. Accepted meetings will be scheduled instantly. Early scheduling maximizes your meeting success.
Don’t miss this opportunity to meet with leading industry investors and potential partners from China, US, and other counties.
| Register Now |
Partial Investors List
|